This company has been marked as potentially delisted and may not be actively trading. HilleVax (HLVX) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Get the Latest News and Ratings for HLVX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for HilleVax and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HLVX Analyst Ratings Over TimeTypeCurrent Forecast10/24/24 to 10/24/251 Month Ago9/24/24 to 9/24/253 Months Ago7/26/24 to 7/26/251 Year Ago10/25/23 to 10/24/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)Hold2 Hold rating(s)2 Hold rating(s)1 Hold rating(s)6 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$2.00$2.00$2.00$9.20Forecasted Upside-4.31% Downside-4.31% Downside-6.98% Downside405.49% UpsideConsensus RatingHoldHoldHoldHold HLVX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History HLVX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table HilleVax Stock vs. The CompetitionTypeHilleVaxMedical CompaniesS&P 500Consensus Rating Score 2.00 2.33 2.52Consensus RatingHoldHoldModerate BuyPredicted Upside-4.31% Downside1,305.06% Upside12.16% UpsideNews Sentiment RatingNeutral NewsSee Recent HLVX NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails8/8/2025Zacks Research0 of 5 stars UpgradeHold3/31/2025HC Wainwright2 of 5 starsMatthew Caufield5 of 5 starsReiterated RatingNeutral$2.00 ➝ $2.00+25.79%7/9/2024Leerink Partnrs1 of 5 starsD. Risinger Not RatedDowngradeStrong-Buy ➝ Hold7/9/2024Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeOutperform ➝ Market Perform$28.00 ➝ $2.00+17.30%7/9/2024Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeBuy ➝ Hold$34.00 ➝ $3.00+82.93%7/8/2024GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingS. FernandezSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral7/8/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOverweight ➝ Neutral$24.00 ➝ $5.00+168.82%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:07 AM ET. HLVX Forecast - Frequently Asked Questions What is HilleVax's forecast for 2025? According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for HilleVax is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. Should I buy or sell HilleVax stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HilleVax in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLVX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLVX, but not buy additional shares or sell existing shares. Does HilleVax's stock price have much downside? According to analysts, HilleVax's stock has a predicted downside of -4.31% based on their 12-month stock forecasts. Has HilleVax been upgraded by Wall Street analysts recently? Over the previous 90 days, HilleVax's stock had 1 upgrade by analysts. What analysts cover HilleVax? HilleVax has been rated by research analysts at Zacks Research in the past 90 days. Do Wall Street analysts like HilleVax more than its competitors? Analysts like HilleVax less than other "medical" companies. The consensus rating score for HilleVax is 2.00 while the average consensus rating score for "medical" companies is 2.33. Learn more on how HLVX compares to other companies. Stock Forecasts and Research Tools Related Companies Amarin Stock Forecast Kamada Stock Forecast Aura Biosciences Stock Forecast Editas Medicine Stock Forecast Larimar Therapeutics Stock Forecast LB Pharmaceuticals Stock Forecast Tectonic Therapeutic Stock Forecast Mereo BioPharma Group Stock Forecast Altimmune Stock Forecast DiaMedica Therapeutics Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:HLVX) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredBuffett’s Retirement PlayIn 2022, when Larry Benedict called the peak of the market, those who stayed in oil were slaughtered. Meanw...Brownstone Research | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.